Supernus Pharmaceuticals Inc (NASDAQ: SUPN) has reported E.P.S. of $0.36 for its second fiscal quarter (ending June 30) versus $-0.02 for the same period a year ago. Relative to the consensus estimate of $0.39, this […]
For its second fiscal quarter (ending June 30), IDEXX Laboratories Inc (NASDAQ: IDXX) has reported a -9% decline in E.P.S. from $2.70 a year ago to $2.46 in the current quarter. This result fell short […]
For its second fiscal quarter (ending June 30), Hudson Technologies Inc (NASDAQ: HDSN) has reported a -50% decline in E.P.S. from $0.42 a year ago to $0.21 in the current quarter. This performance was $-0.05 […]
Hallador Energy Co (NASDAQ: HNRG) has reported E.P.S. of $-0.27 for its second fiscal quarter (ending June 30) versus $0.51 for the same period a year ago — a decline of -153%. Relative to the […]
For its second fiscal quarter (ending June 30), Centrus Energy Corp (NYSEAMERICAN: LEU) has reported a 125% increase in E.P.S. from $0.84 a year ago to $1.89 in the current quarter. This result exceeded the […]
Trex Co Inc (NYSE: TREX) has reported earnings for its second fiscal quarter (ending June 30) of $0.80 versus $0.71 for the same period a year ago — an increase of 13%. This result exceeded […]
HUTCHMED (China) Limited (NASDAQ: HCM) stock closed at $20.22 on 8/6/24 after a major increase of 10.9%. Moreover, above average trading volume at 127% of normal accompanied the advance. The stock has risen 10.6% during […]
Crexendo Inc (NASDAQ: CXDO) has reported E.P.S. of $0.02 for its second fiscal quarter (ending June 30) versus $-0.02 for the same period a year ago. Relative to the consensus estimate of $0.05, this was […]
Recent important negative changes in fundamentals have impacted ASGN Inc (NYSE: ASGN): significant quarterly sales deceleration occurred, the consensus estimate for December, 2024 decreased significantly, and the consensus estimate for December, 2025 decreased significantly. Recent […]
On 8/5/24, Marker Therapeutics Inc (NASDAQ: MRKR) stock suffered a major decline of -11.2%, closing at $3.90. Moreover, trading volume in this decline was exceptionally high at 258% of normal. Relative to the market the […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research